Your browser doesn't support javascript.
loading
Preclinical systematic review of ginsenoside Rg1 for cognitive impairment in Alzheimer's disease.
Liang, Hai-Yong; Zhang, Pei-Pei; Zhang, Xi-Le; Zheng, Yan-Yan; Huang, Yan-Ran; Zheng, Guo-Qing; Lin, Yan.
Afiliação
  • Liang HY; Department of Neurology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325000, China.
  • Zhang PP; Department of Neurology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325000, China.
  • Zhang XL; Department of Neurology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325000, China.
  • Zheng YY; Department of Neurology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325000, China.
  • Huang YR; Department of Neurology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325000, China.
  • Zheng GQ; Department of Neurology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325000, China.
  • Lin Y; Department of Neurology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou 325000, China.
Aging (Albany NY) ; 13(5): 7549-7569, 2021 03 03.
Article em En | MEDLINE | ID: mdl-33686024

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Nootrópicos / Ginsenosídeos / Doença de Alzheimer / Disfunção Cognitiva Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Nootrópicos / Ginsenosídeos / Doença de Alzheimer / Disfunção Cognitiva Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China